iKang Healthcare (KANG) Reports Q3 EPS of $0.40
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil, producer inflation weaken
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
iKang Announces Unaudited Financial Results for the Fiscal Third Quarter Ended December 31, 2017
March 22, 2018 5:00 PM EDTBEIJING, March 22, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), major provider in Chinas fast growing private preventive healthcare services market, today announced its unaudited financial results for the fiscal third quarter ended December 31, 2017.
Fiscal Third Quarter Ended December 31, 2017 Financial Highlights
Net revenues were US$206.4 million, an increase of 33.5% year-over-year (an increase of 29.3% on RMB basis) (1) Gross profit was US$104.9 million, an increase of 43.5% year-over-year (an increase of 38.9% on RMB basis) (1) Net income attributable to the Company was US$27.1... More
